ABOLOGIX Sàrl

ABOLOGIX Sàrl, limited liability company in Plan-les-Ouates (GE), pharmaceuticals. Registration active in the commercial register since 2018. Latest publication: March 2, 2022. UID CHE-223.149.950.

Abologix is a biopharmaceutical company based in Geneva, Switzerland. It is developing monoclonal antibodies that selectively block two novel pharmacological targets, with several oncological medical indications being pursued.¹

Commercial register

Legal form: Limited liability company Sàrl/GmbH
Registered office: c/o Fondation Genevoise pour l'Innovation Technologique Route de la Galaise 34, 1228 Plan-les-Ouates
Share capital: CHF 20,000
UID: CHE-223.149.950
Registered since: 2018
Registered purpose (original language): recherche, développement, fabrication et commercialisation de produits pharmaceutiques (cf. statuts pour but complet).

All 72 companies registered at this address

Similar companies

BioXpress Therapeutics SA Monthey Scientific research and development
IGI Therapeutics SA Neuchâtel Manufacture of basic pharmaceutical products
INFLAMALPS SA Monthey Scientific research and development
AB2 Bio SA Ecublens (VD) Manufacture of basic pharmaceutical products
Signal26 Biotherapeutics SA Epalinges Manufacture of basic pharmaceutical products
Biodelphis Therapeutics SA Lausanne Scientific research and development

A free account opens every company that looks like ABOLOGIX Sàrl, and what they have in common. Create a free account

Register publications

The commercial register publishes each notice only in the language of the registry office concerned, and Prospex reproduces it unchanged.

Address changed March 2, 2022

ABOLOGIX Sàrl, à Plan-les-Ouates, CHE-223.149.950 (FOSC du 07.02.2018, p. 0/4042169). Nouvelle adresse: Route de la Galaise 34, c/o Fondation Genevoise pour l'Innovation Technologique, 1228 Plan-les-Ouates.

Source: Swiss Official Gazette of Commerce (FOSC).

¹ This information was estimated by machine learning and may contain errors.